Jean E Abraham

9PUBLICATIONS
112CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 06, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.

Rebecca A Burrell, Sanjeev Kumar, Elena Provenzano

|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.

Jean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz

|Nov 08, 2024
Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer.

Abigail Shea, Yaniv Eyal-Lubling, Daniel Guerrero-Romero

|Sep 04, 2024
Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility.

Shadi Basyuni, Laura Heskin, Andrea Degasperi

|Apr 08, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.

Jean E Abraham, Karen Pinilla, Alimu Dayimu

|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.

Angela Santonja, Wendy N Cooper, Matthew D Eldridge

Pageof 2

Frequent Collaborators

6 joint publications

Carlos Caldas

3 joint publications

Karen Pinilla Alba

3 joint publications

Marc Tischkowitz

3 joint publications

Wendi Qian